Prevention of Mouse AA with IL-15 pathway inhibitors

ABSTRACT: Our goal was to identify gene expression patterns that correlated with prevention of autoimmune alopecia in C3H/HeJ mice following alopecic graft transplantation skin from 3-5 mice were taken at 5/6 weeks and 12/13 weeks of drug administration following grafting; mice were treated with ruxolitinib (jak12i) by oral gavage, tofacitinib (jak3i) by osmotic pump, antiIL15R-beta antibody by i.p. injection, or control pbs by either ip injection, oral gavage, or osmotic pump. sham indicates mice that received no graft. 3-5 biological replicates were taken at each time point for each treatment modality

ORGANISM(S): Mus musculus

SUBMITTER: Ali Jabbari 

PROVIDER: E-GEOD-45551 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress